» Articles » PMID: 27862119

Increased Expression of Nerve Growth Factor Correlates with Visceral Hypersensitivity and Impaired Gut Barrier Function in Diarrhoea-predominant Irritable Bowel Syndrome: a Preliminary Explorative Study

Overview
Date 2016 Nov 19
PMID 27862119
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neural-immune-endocrine network mechanism has attracted increased attention in diarrhoea-predominant irritable bowel syndrome (IBS-D). Pre-clinical evidence indicates that nerve growth factor (NGF) mediates visceral hypersensitivity and gut barrier dysfunction, via interactions with mast cells and sensory nerve fibres.

Aim: To explore the role of nerve growth factor, as well as mast cell-nerve growth factor-nerve interaction in IBS-D pathophysiology.

Methods: In this cross-sectional study, IBS-D patients and healthy controls first underwent clinical and psychological assessments. Visceral sensitivity to rectal distension was tested. As gut barrier function markers, serum diamine oxidase and d-lactate were detected. Rectosigmoid biopsies were taken for the analyses of nerve growth factor expression, mast cell count and activation, and sensory nerve fibres expressing transient receptor potential vanilloid 1 and calcitonin gene-related peptide. Correlations between these parameters were examined in patients.

Results: Thirty-eight IBS-D patients (28 males, 10 females; average age 30.2 years) and 20 healthy controls (12 males, 8 females; average age 26.8 years) participated in the study. The patients presented increased psychological symptoms, visceral hypersensitivity and impaired gut barrier function. NGF gene expression, mast cell count and sensory nerve fibres were significantly increased in the patients (P < 0.05). In correlation analysis, NGF expression was positively correlated with the disease severity, anxiety and serum diamine oxidase; visceral sensitivity thresholds were negatively associated with NGF expression (Bonferroni corrected P < 0.0029).

Conclusions: Elevated mucosal NGF may interact with mast cells and sensory nerve fibres, contributing to visceral hypersensitivity and impaired gut barrier function in IBS-D.

Citing Articles

Exploration of Cytokines and Microbiome Among Males and Females with Diarrhea-Predominant Irritable Bowel Syndrome.

Chen L, Plantinga A, Burr R, Cain K, Barney P, Savidge T Dig Dis Sci. 2025; .

PMID: 39779588 DOI: 10.1007/s10620-024-08836-5.


Targeting nerve growth factor for pain relief: pros and cons.

Jaffal S, Khalil R Korean J Pain. 2024; 37(4):288-298.

PMID: 39322310 PMC: 11450303. DOI: 10.3344/kjp.24235.


Neural circuits regulating visceral pain.

Chang X, Zhang H, Chen S Commun Biol. 2024; 7(1):457.

PMID: 38615103 PMC: 11016080. DOI: 10.1038/s42003-024-06148-y.


The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome.

Wu B, Xu P, Cheng L, Wang Q, Qiu H, Yan X Clin Exp Immunol. 2024; 216(2):200-210.

PMID: 38290436 PMC: 11036107. DOI: 10.1093/cei/uxae006.


Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships.

Yuan Y, Wang X, Huang S, Wang H, Shen G Gut Microbes. 2023; 15(2):2263209.

PMID: 37786296 PMC: 10549202. DOI: 10.1080/19490976.2023.2263209.